July 13, 2024

DNS Africa Resource Center

..sharing knowledge.

Author Correction: Evaluation of recombinant human IGF-1/IGFBP-3 on intraventricular hemorrhage prevention and … – Nature.com

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Scientific Reports volume 14, Article number: 9423 (2024)
103 Accesses
Metrics details
The Original Article was published on 13 November 2023
Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-46611-0, published online 13 November 2023
The original version of this Article contained an error in the Results section, under the subheading ‘Treatment with rhIGF-1/rhIGFBP-3 and rate of survival’,
“The survival at 48 h following IVH was 63.6% (n = 7 out of 11) in the vehicle administered group and 87.5% (n = 7 out of 8) in the rhIGF-1/rhIGFBP-3 administered group (Fig. 2 and Table 3).”
now reads:
“The survival at 48 h following IVH was 72.7% (n = 8 out of 11) in the vehicle administered group and 87.5% (n = 7 out of 8) in the rhIGF-1/rhIGFBP-3 administered group (Fig. 2 and Table 3).”
Additionally, as the result of this error, Figure 2 was incorrect. The original Figure 2 and accompanying legend appear below.
Survival in experiment B. Preterm rabbit pups were s.c. administered with rhIGF-1/rhIGFBP-3 (8 mg/kg/dose, n = 38) or vehicle (n = 39) at approximately 3 h of age, and thereafter every 12 h for a total of 5 administrations. A single i.p. bolus of 50% glycerol solution was administered at 6 h of age to induce IVH. Animals were followed up until 54 h of postnatal age, corresponding to 48 h post-glycerol administration, at which point the extent of bleeding was assessed by HFU (bleedings were scored as IVH or No IVH), and survival was evaluated. For details of the experiment and results see “Methods” and “Results” sections. Results are presented in a bar graph. Differences between groups were analyzed using Fischer’s exact test with P-value and the difference between proportions as attributable risk in percent (%).
The original Article has been corrected.
These authors contributed equally: David Ley and Magnus Gram.
Pediatrics, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden
Claes Ekström, Amanda Kristiansson, Åsa Jungner, David Ley & Magnus Gram
Pediatrics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden
Niklas Ortenlöf & Suvi Vallius
ImaGene-iT AB, Lund, Sweden
Bo Holmqvist
Institute of Neuroscience and Physiology, Sahlgrenska Academy, Department of Obstetrics and Gynecology, University of Gothenburg, Gothenburg, Sweden
Xiaoyang Wang
Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Ann Hellström
Scientific Advisory Board, Oak Hill Bio Ltd, WA14 2DT, UK
Norman Barton
Takeda, Cambridge, MA, USA
Galen Carey
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
Correspondence to Magnus Gram.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and permissions
Ekström, C., Ortenlöf, N., Kristiansson, A. et al. Author Correction: Evaluation of recombinant human IGF-1/IGFBP-3 on intraventricular hemorrhage prevention and survival in the preterm rabbit pup model. Sci Rep 14, 9423 (2024). https://doi.org/10.1038/s41598-024-60175-7
Download citation
Published:
DOI: https://doi.org/10.1038/s41598-024-60175-7
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Advertisement
Scientific Reports (Sci Rep) ISSN 2045-2322 (online)
© 2024 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

source

About The Author